immunotherapy

NY-ESO-1 protein has higher expression in the well differentiated and the bigger tumor tissues of TSCC. It can be further explored as one of the basic research in multivalent vaccine immunotherapy of TSCC.

结论：1NY-ESO-1蛋白在中高分化及肿块较大的TSCC组织中表达较高，可以进一步探索其作为TSCC免疫治疗多价疫苗的基础研究依据之一。

Instead, his oncologist, Dr. Matthew D. Hellmann of Memorial Sloan Kettering Cancer Center in New York City, recommended an experimental treatment: immunotherapy.

但如今，他的主治医生、纽约市纪念斯隆·凯特琳癌症中心（Memorial Sloan Kettering Cancer Center）的肿瘤学医师马修·D·霍尔曼博士（Dr.Matthew D.Hellmann）推荐了尚在实验中的免疫疗法。

Objective To study if cryotherapy combined with immunotherapy could achieve better therapeutic effect than either used alone.

目的探讨冷冻治疗附加免疫治疗可能获得更好的抗肿瘤疗效。